PSMA and Sigma-1 receptor dual-targeted peptide mediates superior radionuclide imaging and therapy of prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PSMA and Sigma-1 receptor dual-targeted peptide mediates superior radionuclide imaging and therapy of prostate cancer

Published:2024-11 Issue: Volume:375 Page:767-775
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Huangfu Zhenyuan,Yang Jiangtao,Sun Juan,Xu Bin,Tao Lei,Wu Jiang,Wang Feng,Wang Guanglin,Meng Fenghua,Zhong Zhiyuan

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference65 articles.

1. Precision radiation opens a new window on cancer therapy;Senior;Nat. Biotechnol.,2024

2. Radiotheranostics in oncology: current challenges and emerging opportunities;Bodei;Nat. Rev. Clin. Oncol.,2022

3. Radiotheranostics: a roadmap for future development;Herrmann;Lancet Oncol.,2020

4. Radiopharmaceutical therapy in cancer: clinical advances and challenges;Sgouros;Nat. Rev. Drug Discov.,2020

5. Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications;Banerjee;Chem. Rev.,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA damage repair inhibitors boost targeted radionuclide therapy and immunotherapy of prostate cancer;Apoptosis;2025-06-26

2. D-mannose augments targeted radioligand-immunotherapy of prostate cancer by enhancing radiosensitivity and reshaping immune microenvironment;Drug Delivery and Translational Research;2025-06-14

3. Radionuclide-Labeled Biomaterials: A Novel Strategy for Tumor-Targeted Therapy;Biomimetics;2025-06-11

4. Photothermal treatment of prostate tumor with micellar indocyanine green and napabucasin to co-ablate cancer cells and cancer stem cells;Journal of Controlled Release;2025-06

5. Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy;Journal of Controlled Release;2025-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3